SCHEMBL13178115

SCHEMBL13178115

COc1cccc(C(C)(C)CN2CCOCC2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 2/20 0.52
TSHR P16473 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.49
CYP2C19 P33261 2/20 0.47
CYP2C9 P11712 1/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
ACHE P22303 1/20 0.45
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3696017 0.76 F10 (0.41) SMN1; SMN2ALDH1A1TSHRL3MBTL1CYP3A4
SCHEMBL13498470 0.74 ALDH1A1 (0.58) SMN1; SMN2ALDH1A1TSHRNPSR1RAB9A
SCHEMBL13791587 0.74 SIGMAR1 (0.72) SMN1; SMN2ALDH1A1TSHRNPSR1RAB9A
Hydrochloric Acid SCHEMBL11194141 0.73 LMNA (0.51) SMN1; SMN2ALDH1A1TSHRRAB9ANPC1
SCHEMBL12449601 0.72 SIGMAR1 (0.58) SMN1; SMN2ALDH1A1NPSR1RAB9ANPC1
SCHEMBL31525392 0.72 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1NPSR1L3MBTL1LMNA
SCHEMBL3435840 0.72 KIF11 (0.46) SMN1; SMN2ALDH1A1CYP2C9RAB9ANPC1
SCHEMBL8705771 0.72 KIF11 (0.46) SMN1; SMN2ALDH1A1TSHRRAB9ANPC1
SCHEMBL5591935 0.71 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1TSHRRAB9ANPC1
SCHEMBL11937211 0.71 ALDH1A1 (0.59) SMN1; SMN2ALDH1A1TSHRNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010111406-A2 COMPOUNDS AND THERAPEUTIC USES THEREOF MYRIAD PHARMACEUTICALS, INC. (US) 2010-09-30 WO disclosed